Iuliani, M.; Simonetti, S.; Ribelli, G.; Cavaliere, S.; Vincenzi, B.; Tonini, G.; Pantano, F.; Santini, D.
Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation. Biomedicines 2022, 10, 2154.
https://doi.org/10.3390/biomedicines10092154
AMA Style
Iuliani M, Simonetti S, Ribelli G, Cavaliere S, Vincenzi B, Tonini G, Pantano F, Santini D.
Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation. Biomedicines. 2022; 10(9):2154.
https://doi.org/10.3390/biomedicines10092154
Chicago/Turabian Style
Iuliani, Michele, Sonia Simonetti, Giulia Ribelli, Silvia Cavaliere, Bruno Vincenzi, Giuseppe Tonini, Francesco Pantano, and Daniele Santini.
2022. "Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation" Biomedicines 10, no. 9: 2154.
https://doi.org/10.3390/biomedicines10092154
APA Style
Iuliani, M., Simonetti, S., Ribelli, G., Cavaliere, S., Vincenzi, B., Tonini, G., Pantano, F., & Santini, D.
(2022). Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation. Biomedicines, 10(9), 2154.
https://doi.org/10.3390/biomedicines10092154
